By Economic Times – Experts criticise India’s endorsement for use of hydroxychloroquine on Covid-19 patients New Delhi: Some experts have criticised the endorsement by India’s top health research body for use of hydroxychloroquine (HCQ) on Covid-19 patients and healthcare workers without proper evidence that proves the drug’s ability to reduce the viral load. In the absence of credible evidence, a blanket recommendation for chemoprophylaxis might be contentious, the experts said in an article published online by the Lancet on April 17. Prophylaxis refers to treatment given to prevent a disease. “The shortage of chloroquine, an inexpensive antimalarial in low-income malaria-endemic countries like India, could lead to preventable morbidity and mortality,” wrote Sahaj Rathi, Ashwini Kalantri and Shriprakash Kalantri from the Mahatma Gandhi Institute of Medical Sciences, Sevagram, and Pranav Ish of Vardhaman Mahavir Medical College and Safdarjung Hospital, New Delhi. The experts said t...
Comments
Post a Comment